Literature DB >> 12675512

Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.

Jin Ah Kwon1, Hyune Mo Rho.   

Abstract

Hepatitis B virus (HBV) is a causative agent of chronic and acute hepatitis, and is associated with the development of hepatocellular carcinoma (HCC). We demonstrate here that the Hepatitis B viral core protein (HBc) functions as a repressor on the promoter activity of the human p53 gene. The functional analyses of the promoter of the p53 gene by serial deletion, site-directed mutagenesis, and the heterologous promoter system revealed that the promoter activity was repressed through the E2F1-binding site (nucleotides -28 to -8) by HBc. An electrophoretic mobility shift assay (EMSA) showed that the HBc reduced the DNA-binding ability of E2F1 to the binding site of the p53 promoter. The interaction of HBc with E2F1 was also observed by glutathione S-transferase (GST) fusion protein binding assay. Furthermore, HBc represses the expression of the p53 gene in the human liver cell line HepG2. Finally, HBc and HBx synergistically repress both the promoter activity and the expression of the p53 gene in HepG2 cells. These results, together with our previous study, strongly suggest that HBc, like HBx, represses the expression of the human p53 tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675512     DOI: 10.1515/BC.2003.022

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  12 in total

Review 1.  The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.

Authors:  Ahmed Diab; Adrien Foca; Fabien Zoulim; David Durantel; Ourania Andrisani
Journal:  Antiviral Res       Date:  2017-11-26       Impact factor: 5.970

Review 2.  Potential mechanisms of hepatitis B virus induced liver injury.

Authors:  Mohd Suhail; Hany Abdel-Hafiz; Ashraf Ali; Kaneez Fatima; Ghazi A Damanhouri; Esam Azhar; Adeel Ga Chaudhary; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

3.  At a crossroads: human DNA tumor viruses and the host DNA damage response.

Authors:  Pavel A Nikitin; Micah A Luftig
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

4.  Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes.

Authors:  Sheng-Quan Zou; Zhen-Liang Qu; Zhan-Fei Li; Xin Wang
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

5.  Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.

Authors:  Thomas Lahlali; Jan Martin Berke; Karen Vergauwen; Adrien Foca; Koen Vandyck; Frederik Pauwels; Fabien Zoulim; David Durantel
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

6.  Human Hepatitis B Virus Core Protein Inhibits IFNα-Induced IFITM1 Expression by Interacting with BAF200.

Authors:  Tongya Li; Zunlong Ke; Weiyong Liu; Ying Xiong; Ying Zhu; Yingle Liu
Journal:  Viruses       Date:  2019-05-09       Impact factor: 5.048

Review 7.  Triangular Relationship between p53, Autophagy, and Chemotherapy Resistance.

Authors:  Jingwen Xu; Nipa H Patel; David A Gewirtz
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

8.  Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis.

Authors:  P Chudasama; A Konrad; R Jochmann; B Lausen; P Holz; E Naschberger; F Neipel; N Britzen-Laurent; M Stürzl
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867

9.  Hepatitis B viral core protein disrupts human host gene expression by binding to promoter regions.

Authors:  Yanhai Guo; Wei Kang; Xiaoying Lei; Yongnian Li; An Xiang; Yonglan Liu; Jinrong Zhao; Ju Zhang; Zhen Yan
Journal:  BMC Genomics       Date:  2012-10-22       Impact factor: 3.969

10.  CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells.

Authors:  Jia Song; Xiaochao Zhang; Qianyun Ge; Chaoyi Yuan; Liang Chu; Hui-Fang Liang; Zhibin Liao; Qiumeng Liu; Zhanguo Zhang; Bixiang Zhang
Journal:  J Cell Biochem       Date:  2018-06-15       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.